WEDNESDAY, Feb. 14, 2018 — A new drug that can stall the progression of a particularly hard-to-treat form of prostate cancer has been approved for use by U.S. health officials.
In a recent study, the drug called Erleada (apalutamide) has shown…Original Article
FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer
